Challenger (CGF.AX) saw a 19% surge in Q3 Life sales to A$1.7 billion, though total Funds Under Management fell to A$104.5 billion. The company has narrowed its FY26 earnings guidance and announced the redemption of specific capital notes.
- Q3 Life sales rose 19% to A$1.7 billion
- FUM decreased 10% to A$104.5 billion due to outflows and market volatility
- FY26 normalized basic EPS guidance narrowed to 66-70 cents
- Capital Notes 3 to be redeemed on May 25, 2026
- Market movements linked to conflict in Iran impacted investment values
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.